SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BJCT-BIOJECT-needle less injection product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dorothy sg who wrote (4)3/9/1997 5:23:00 PM
From: Blue Fish   of 534
 
Dorothy:

sorry. my initial post wasn't very fair.

i've followed bjct rather closely, as a relative owns the stock. as i am sure you are already aware, the stock has suffered the past couple of years (not including the recent price run and subsequent drop, at which time bjct's stock price doubled within a few days, only to drop back down to its previous level).

bjct's product is not so unique anymore, as there are other companies making a needless injection system. the initial euphoria surrounding bjct had alot to do with the HIV crisis. and while people can still contract HIV via sharing needles, the fact is the story is no longer a big news item. bjct's stock price, imo, has dropped as a result of this. (bjct has a five year high of around $8, and now they are at .75). so when i said "you'll have a long wait," i was refering to any great increase in the stock price. i do feel the company makes a good product but this doesn't in itself mean the stock price is going to go up.

it's quite possible, knowing bjct's stock price movement, that bjct could double next week. and if i were a bjct stockholder, i'd dump it in a heart beat. the stock just can't sustain any gains.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext